New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2013
10:14 EDTORIG, LM, FIATY, WFC, SNX, MERC, KGC, DF, WAB, PRU, MPLX, KS, BIIB, USBOn the Fly: Downgrade Summary
Biogen (BIIB) downgraded to Neutral from Buy at Citigroup… Dean Foods (DF) downgraded to Market Perform from Outperform at Bernstein… Fiat (FIATY) downgraded to Neutral from Buy at UBS… KapStone (KS) downgraded to Hold from Buy at Deutsche Bank… Kinross Gold (KGC) downgraded to Market Perform from Outperform at Cowen… Legg Mason (LM) downgraded to Sell from Neutral at Goldman… MPLX (MPLX) downgraded to Neutral from Buy at BofA/Merrill… Mercer (MERC) downgraded to Sector Underperformer from Sector Performer at CIBC… Ocean Rig UDW (ORIG) downgraded to Neutral from Outperform at Credit Suisse… Prudential (PRU) downgraded to Outperform from Top Pick at RBC Capital… SYNNEX (SNX) downgraded to Market Perform from Outperform at Raymond James… U.S. Bancorp (USB) downgraded to Underweight from Neutral at Atlantic Equities… Wabtec (WAB) downgraded to Market Perform from Outperform at Raymond James… Wells Fargo (WFC) downgraded to Underweight from Neutral at Atlantic Equities.
News For BIIB;DF;FIATY;KS;KGC;LM;MPLX;MERC;ORIG;PRU;SNX;USB;WAB;WFC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 25, 2015
11:12 EDTWFCNumerous analysts upgrade Bank of America amid market rebound
Subscribe for More Information
09:59 EDTUSBOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:19 EDTUSBU.S. Bancorp upgraded to Outperform from Sector Perform at Portales
Subscribe for More Information
09:03 EDTBIIBAcorda has major overhang removed by IPR denials, says Leerink
Subscribe for More Information
08:58 EDTSNXStifel technology analyst holds an analyst/industry conference call
Senior Technology & Regulatory Analyst Brian Stephens discusses the recently expanded Federal E-rate funding program for public and private school districts to upgrade their networking infrastructures (including wi-fi), and its impact on IT solution providers and distributors, as well as the significant opportunities for a number of covered companies including CDW, Insight, ePlus, Ingram and Synnex, on an Analyst/Industry conference call to be held on August 27 at 11 am.
August 24, 2015
12:26 EDTWFCAvolon Capital acquires Airbus A321-200 aircraft on lease to Vueling Airlines
Subscribe for More Information
09:45 EDTKGCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:48 EDTUSBU.S. Bancorp volatility at high end of range
Subscribe for More Information
07:01 EDTWFCWells Fargo volatility at high end of range
Subscribe for More Information
07:00 EDTKGCKinross Gold downgraded to Underperform from Sector Perform at RBC Capital
Subscribe for More Information
August 21, 2015
09:38 EDTBIIBUBS global healthcare analysts hold an analyst/industry conference call
Subscribe for More Information
August 20, 2015
16:24 EDTBIIBBiogen reports 8.1% passive stake in Applied Genetic
Subscribe for More Information
10:00 EDTUSBOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:48 EDTWFCStocks with implied volatility movement; WFC XLI
Stocks with implied volatility movement; Wells Fargo (WFC) 16, Industrial Select Sector SPDR (XLI) 18 according to iVolatility.
August 19, 2015
17:46 EDTBIIBApplied Genetic says Biogen collaboration effective, equity investment closed
Subscribe for More Information
17:12 EDTUSBU.S. Bancorp initiated with a Neutral at Sterne Agee CRT
Subscribe for More Information
August 18, 2015
17:35 EDTWFCWells Fargo to build additional car loan branches, Reuters says
Subscribe for More Information
08:21 EDTBIIBBiogen long-term outlook still positive, says RBC Capital
Subscribe for More Information
07:05 EDTBIIBBiogen, ALS Association, Columbia collaborate to drive understanding of ALS
Biogen, the ALS Association and Columbia University Medical Center announced a new collaboration to better understand the differences and commonalities in the ALS disease process and how genes influence the clinical features of the disease. The project, "Genomic Translation for ALS Clinical care", will involve a combination of next generation genetic sequencing and detailed clinical phenotyping in 1500 people with ALS. The goal of the project is to provide a basis for the development of precision medicine, or more individually tailored therapies for ALS. "We want to bring genomics right to the point of care in ALS where instead of focusing on retrospective DNA samples with limited clinical information, we focus on patients who are under active clinical management," said ALS Association Chief Scientist Lucie Bruijn, Ph.D., M.B.A. "By focusing on patients seen by participating ALS clinics, this project will allow investigators to ask how different genetic causes of ALS translate into different clinical consequences."
August 17, 2015
07:03 EDTBIIBBiogen: Clinical data supports long-term safety, efficacy of Alprolix
New clinical data support the long-term safety and efficacy of ALPROLIX in people with severe hemophilia B treated for up to two years, Biogen announced. Participants in the Phase 3, open-label extension study, B-YOND, maintained low bleeding rates with one to two week prophylaxis regimens, according to data from an interim analysis. Investigators presented these interim results for the first time at the 67th Annual Meeting for the National Hemophilia Foundation in Dallas. B-YOND is a multi-year study for people with severe hemophilia B who completed the Phase 3 pivotal B-LONG or Kids B-LONG studies. In this interim analysis, the median time on ALPROLIX during B-YOND was 27.6 months for adults and adolescents, and 47.7 weeks for children under age 12. The study's primary endpoint is inhibitor development, and no inhibitors have been reported to-date. There were three prophylactic dosing options for adult, adolescent, and pediatric participants in the B-YOND trial - weekly, individualized, and modified prophylaxis. An episodic treatment arm was also available for adult and adolescent patients.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use